The Utility of Mass Spectrometry in Defining Minimal Residual Disease in Treated Multiple Myeloma Patients

被引：0
|
作者：
Campbell, Lauren [1 ]
Lau, I-Jun [2 ]
Ramasamy, Karthik [3 ]
Sadler, Ross [1 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[2] Botnar Inst, Oxford, England
[3] Radcliffe Dept Med, Oxford, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-184
引用
收藏
页码：S144 / S145
页数：2
相关论文
共 50 条
  • [1] Measuring Minimal Residual Disease in Plasma of Multiple Myeloma Patients By Intact Mass Spectrometry
    Genovesi, Luca
    Schirm, Michael
    Dupuis, Nick
    Pottiez, Gwenael
    BLOOD, 2023, 142
  • [2] M-protein detection by mass spectrometry for minimal residual disease in multiple myeloma
    Guan, Lihua
    Su, Wei
    Zhong, Jian
    Qiu, Ling
    CLINICA CHIMICA ACTA, 2024, 552
  • [3] Mass spectrometry methods for detecting monoclonal immunoglobulins in multiple myeloma minimal residual disease
    Thoren, Katie L.
    SEMINARS IN HEMATOLOGY, 2018, 55 (01) : 41 - 43
  • [4] Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma
    Foureau, David
    Bhutani, Manisha
    Guo, Fei
    Rigby, Katherine
    Leonidas, Marina
    Tjaden, Elise
    Fox, Andee
    Atrash, Shebli
    Paul, Barry
    Voorhees, Peter M.
    Usmani, Saad Z.
    CANCER MEDICINE, 2021, 10 (20): : 6933 - 6936
  • [5] Personalized mass spectrometry as a tool for minimal residual disease detection in the blood of myeloma patients
    Noori, Somayya
    Wijnands, Charissa
    Bonifay, Vincent
    Luider, Theo
    Sonigo, Pierre
    Dejoie, Thomas
    Gloerich, Jolein
    van Gool, Alain
    van Duijn, Martijn
    Jacobs, Joannes
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S75 - S75
  • [6] Minimal residual disease diagnostics in patients with multiple myeloma
    Huhn, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 128 - 128
  • [7] Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry
    Somayya Noori
    Charissa Wijnands
    Pieter Langerhorst
    Vincent Bonifay
    Christoph Stingl
    Cyrille Touzeau
    Jill Corre
    Aurore Perrot
    Philippe Moreau
    Hélène Caillon
    Theo M. Luider
    Thomas Dejoie
    Joannes F. M. Jacobs
    Martijn M. van Duijn
    Blood Cancer Journal, 13
  • [8] Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry
    Noori, Somayya
    Wijnands, Charissa
    Langerhorst, Pieter
    Bonifay, Vincent
    Stingl, Christoph
    Touzeau, Cyrille
    Corre, Jill
    Perrot, Aurore
    Moreau, Philippe
    Caillon, Helene
    Luider, Theo M.
    Dejoie, Thomas
    Jacobs, Joannes F. M.
    van Duijn, Martijn M.
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [9] Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry
    Jacobs, J.
    Noori, S.
    Wijnands, C.
    Gloerich, J.
    Bonifay, V.
    Sonigo, P.
    Luider, T.
    Wessels, H.
    Van, A. Gool
    Dejoie, T.
    Vanduijn, M.
    CLINICA CHIMICA ACTA, 2024, 558
  • [10] Monitoring Minimal Residual Disease in Patients with Multiple Myeloma By Tracking Serum M-Protein Using Mass Spectrometry
    Fan, Huishou
    Wang, Bing
    Qiu, Lugui
    Ma, Bin
    An, Gang
    BLOOD, 2023, 142
12345